Eagle Asset Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $18.8M | Sell |
176,249
-106,102
| -38% | -$11.3M | 0.1% | 196 |
|
|
2024
Q2 | $21.7M | Sell |
282,351
-56,449
| -17% | -$4.34M | 0.12% | 169 |
|
|
2024
Q1 | $22.6M | Sell |
338,800
-15,323
| -4% | -$1.02M | 0.11% | 174 |
|
|
2023
Q4 | $22.2M | Sell |
354,123
-885
| -0.2% | -$55.6K | 0.12% | 177 |
|
|
2023
Q3 | $18.1M | Sell |
355,008
-6,078
| -2% | -$310K | 0.11% | 188 |
|
|
2023
Q2 | $18M | Buy |
361,086
+133,393
| +59% | +$6.66M | 0.1% | 195 |
|
|
2023
Q1 | $8.53M | Buy |
+227,693
| New | +$8.53M | 0.05% | 268 |
|